Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Sesen Bio Inc (SESN)

Sesen Bio Inc (SESN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
BioMarin (BMRN) Refiles BLA With FDA for Hemophilia Gene Therapy

If approved, BioMarin's (BMRN) valoctocogene roxaparvovec will be the first gene therapy for hemophilia A in the United States. The FDA filing also incorporates BMRN's responses to the CRL issued to the...

SNY : 39.82 (-0.75%)
BMRN : 89.53 (+1.84%)
SESN : 0.4799 (-3.15%)
MORF : 28.77 (-0.59%)
SESEN BIO, INC. (SESN) Stock Moves -0.43%: What You Should Know

SESEN BIO, INC. (SESN) closed at $0.39 in the latest trading session, marking a -0.43% move from the prior day.

SESN : 0.4799 (-3.15%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SBET, RMED, OCSL, SESN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SBET : 0.8501 (-3.11%)
RMED : 6.45 (-1.38%)
OCSL : 6.31 (-2.17%)
SESN : 0.4799 (-3.15%)
SESEN BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Sesen Bio, Inc. - SESN

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Sesen Bio, Inc. (NasdaqCM: SESN) (the “Company”)...

SESN : 0.4799 (-3.15%)
Wave Therapeutics (WVE) Up on Update From Huntington's Study

Wave Therapeutics (WVE) provides a positive update from its ongoing phase Ib/IIa study evaluating one of its lead candidates, WVE-003, for Huntington's disease. Stock up.

STSA : 5.18 (-6.50%)
WVE : 3.66 (-2.40%)
SESN : 0.4799 (-3.15%)
ARDS : 1.1500 (+3.60%)
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib

Puma Biotechnology (PBYI) inks license agreement with Japan's Takeda Pharmaceuticals, gaining worldwide development and commercialization rights to the latter's cancer treatment alisertib.

AZN : 56.73 (-0.54%)
BMY : 71.45 (+0.34%)
PBYI : 2.44 (-2.40%)
SESN : 0.4799 (-3.15%)
SESN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Sesen Bio, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Sesen Bio, Inc. (NASDAQ: SESN) and Carisma Therapeutics Inc. is fair to Sesen Bio shareholders. Pre-merger Sesen Bio...

SESN : 0.4799 (-3.15%)
Sesen Bio and Carisma Therapeutics Announce Merger Agreement

Sesen Bio, Inc. (Nasdaq: SESN ) and Carisma Therapeutics Inc. (Carisma), a privately held, clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies,...

SESN : 0.4799 (-3.15%)
SESEN BIO, INC. (SESN) Dips More Than Broader Markets: What You Should Know

SESEN BIO, INC. (SESN) closed at $0.67 in the latest trading session, marking a -1.59% move from the prior day.

SESN : 0.4799 (-3.15%)
Intellia (NTLA) Reports Positive Results for CRISPR Candidates

Intellia Therapeutics (NTLA) reported positive interim results for its CRISPR candidates being evaluated to treat transthyretin (ATTR) amyloidosis and treating hereditary angioedema (HAE).

REGN : 745.68 (+0.83%)
NTLA : 60.92 (+0.07%)
SESN : 0.4799 (-3.15%)
ARDS : 1.1500 (+3.60%)

Barchart Exclusives

Hasbro’s Blueprint 2.0 Aims High. Will It Hit the Target?
Hasbro held its 2022 Investor Day on October 4. The company unveiled its blueprint for growth over the next five years. It might be biting off more than it can chew. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar